Company Update: SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in CBM |
Learn More
Search for:
About us
Leadership team
Direction and location
Code of Conduct and Ethics
Our new 5,000 m2 biomanufacturing site
Services
Bioprocess development (USP & DSP)
cGMP manufacturing of clinical & commercial batches
Analytical Development, Qualification & Validation – QC & QA
Fill & Finish
Regulatory Support
Our platforms
LentiSure™: Lentivirus Manufacturing Platform
AAVelocity™: AAV Manufacturing Platform
Innovation
News, blog & events
News
Blog
Events
Careers
Contact us
Search for:
Blog
All
News
Blog
Events
Case Study: Evaluation of several process cell lysis reagents as replacements for Triton X-100 for rAAV production.
14 November 2023
Read more
Podcast: Building with the patient in mind: Designing a state-of-the-art facility for viral vector manufacturing
13 October 2023
Read more
The Role of a Viral Vector CDMO in the Biotechnology Industry
25 September 2023
Read more
How CAR T Manufacturing is Revolutionizing Cancer Treatment
12 September 2023
Read more
CAR T-Cell Manufacturing: Production and Guidelines
22 August 2023
Read more
Analytical Quality by Design approach: a challenge for Viral Vector Testing in Gene Therapy
5 July 2023
Read more
A large-scale lentivirus manufacturing platform to accelerate time to clinic: video & poster
4 July 2023
Read more
Yposkesi’s new biomanufacturing site: interview with our Chief Operational Officer
23 June 2023
Read more
Efficient transduction of T cells using a suspension-based lentiviral vector system
5 June 2023
Read more
Timelapse video of our new biomanufacturing site in France
23 May 2023
Read more
Load more blogs
Would you like to know more ?
Contact us
